Discovery and clinical translation of ceperognastat, an O‐GlcNAcase (OGA) inhibitor, for the treatment of Alzheimer's disease

Abstract INTRODUCTION The aggregation and spread of hyperphosphorylated, pathological tau in the human brain is hypothesized to play a key role in Alzheimer's disease (AD) as well as other neurogenerative tauopathies. O‐GlcNAcylation, an important post‐translational modification of tau and many...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: William Kielbasa, Paul Goldsmith, Kevin B. Donnelly, Hugh N. Nuthall, Sergey Shcherbinin, Adam S. Fleisher, Jörg Hendle, Susan L. DuBois, Stephen L. Lowe, Feiyu Fred Zhang, Eric M. Woerly, Nicolas J.‐F. Dreyfus, David Evans, Jeremy Gilmore, Michele Mancini, Cristian C. Constantinescu, Roger N. Gunn, David S. Russell, Emily C. Collins, Miroslaw Brys, Michael L. Hutton, Dustin J. Mergott
Format: Artigo
Idioma:Inglês
Publicat: Wiley 2024-10-01
Col·lecció:Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Matèries:
Alzheimer's disease
enzyme occupancy
O‐GlcNAcase inhibition
O‐GlcNAcylation
pharmacokinetics
tau
Accés en línia:https://doi.org/10.1002/trc2.70020
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars